CASC
Cascadian Therapeutics, Inc.
CASC
CASC
Delisted
CASC was delisted on the 8th of March, 2018.
90 hedge funds and large institutions have $103M invested in Cascadian Therapeutics, Inc. in 2015 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 37 increasing their positions, 16 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more call options, than puts
Call options by funds: $91K | Put options by funds: $91K
Holders
90
Holding in Top 10
2
Calls
$91K
Puts
$91K
Top Buyers
| 1 | +$5.75M | |
| 2 | +$2.45M | |
| 3 | +$2.44M | |
| 4 |
First Eagle Investment Management
New York
|
+$2.12M |
| 5 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$1.9M |
Top Sellers
| 1 | -$2.17M | |
| 2 | -$1.85M | |
| 3 | -$1.8M | |
| 4 |
QF
QVT Financial
New York
|
-$1.18M |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$813K |